In a comparison study, benefits of nurse-led preoperative counseling and follow-up care was significantly greater compared with surgeon-led or no counseling models.

Researchers sought to determine whether teclistamab would lead to a clinical response in patients with relapsed/refractory multiple myeloma.

Researchers assessed the impact of cryoablation during lobectomy for lung cancer on opioid use, hospital costs, and patient outcomes.

Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma.

Some patients who had disease progression after stopping larotrectinib achieved a response after resuming larotrectinib.

The diagnosis of spinal cord lymphoma is often delayed due to the high risks associated with a spinal cord biopsy, the rarity of the disease, and the lack of specificity of its clinicoradiological ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

Researchers observed an increase in both CXCR4 and CD5 levels as the cells progressed to later stages of the cell cycle, particularly in the S/G2/M phases.

Researchers compared the effects of conventional treatment with a combination of epirubicin and mindfulness intervention on oncologic and psychologic burden in patients with urinary tract cancers.

Researchers sought to identify prognostic factors for survival in patients with newly diagnosed multiple myeloma.

In a survey, less than half of cancer patients and their family members said they were willing to participate in a clinical trial, and about a third of respondents said they had a positive perception ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.